Concepedia

Alessia Mira

AM

Statistics

Publications

7

Citations

554

H-Index

7

Active since

2008

Affiliations

University of Turin(Current)

Candiolo Cancer Institute

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Broad Institute

Alessia Mira is an author at University of Turin specializing in oncology, medicine, and molecular biology.

ORCID

Publications per year

2008–2024

7

Publications

7

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 318 citations · Full text

, , +16

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

Marie‐Julie Nokin, Alessia Mira, Enrico Patrucco et al. · Nature Communications · 2024 · 54 citations · Full text

, , +4

Four individually druggable MET hotspots mediate HGF-driven tumor progression

Cristina Basilico, Anna Hultberg, Christophe Blanchetot et al. · Journal of Clinical Investigation · 2014 · 53 citations · Full text

, , +15

Met-driven invasive growth involves transcriptional regulation of Arhgap12

Alessandra Gentile, L D'alessandro, Luca Lazzari et al. · Oncogene · 2008 · 40 citations · Full text

, , +5

A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine

Carlos Sebastián, Christina M. Ferrer, Maria Paola Serra et al. · Nature Communications · 2022 · 39 citations · Full text

, , +17

1–5 of 7